
Welcome Address We are pleased to announce that the 12th Brain Tumor Meeting will take place at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin (Germany) in 2024. The Brain Tumor meeting is an open scientific forum organized to foster the development of multi-center, international and inter-disciplinary collaborations that will lead to a better understanding of the etiology, biology, outcomes and prevention of brain tumors. The two-day conference on brain tumor biology and genetics provides an excellent opportunity for clinicians, neuroscientists, neuro-oncologists, Pls, postdocs, PhD students and research technicians to meet, present and discuss their work, build informal networks and set up new collaborations. More than 300 participants and almost 200 poster presentations in 2022 documented the increasing interest in the field. Internationally renowned speakers agreed to present their newest data on these topics. Furthermore, abstracts for oral and poster presentations are invited and the best presentations will be awarded a prize. The Scientific Committee
|
|
Scientific Committee:
Gaetano Gargiulo, MDC, Berlin-Buch
Rainer Glass (Chair), LMU, Munich Charlotte Flüh, UKSH, Kiel
Christoph Harms, Charité Campus Mitte, Berlin
Franz Josef Müller, MPI Berlin
Michael Synowitz (Chair), CAU, Kiel
This meeting is an activity of
Max Delbrück Center for Molecular Medicine (MDC)
Christian-Albrechts-University zu Kiel
Ludwig-Maximilian-Universität München Conference Management:
Sindy Schröder
Verein zur Förderung der Neurowissenschaften Kiel e.V.
c/o Klinik für Neurochirurgie
UKSH Campus Kiel Arnold-Heller-Str. 3, Haus D, 24105 Kiel, Germany
Phone: +49 431 500 23601
|
|
Travel grants available
Best Abstract Competition
Three prizes will be awarded for the best three abstracts presented at the Brain Tumor 2024 meeting. The winners are determined by scoring by program committee members and voting by the meeting participants.
Archive |
Our partners